Press release
Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN)
Palatin Technologies (NYSE American: PTN)* just unveiled remarkable topline results from its Phase 2 study of PL8177 for ulcerative colitis (UC), demonstrating what could be a disruptive new treatment approach for this debilitating inflammatory bowel condition.
The data seems impressive - an extraordinary 78% of patients treated with PL8177 achieved clinical response compared to just 33% for placebo, with statistical significance (p
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Palatin Technologies' UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data - Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN) here
News-ID: 3947959 • Views: …
More Releases from ABNewswire
Brooklyn Car Accident Lawyer Samantha Kucher Warns Drivers About Legal Risks Tie …
Brooklyn car accident lawyer Samantha Kucher (https://www.rrklawgroup.com/drowsy-driving-accidents-in-new-york-why-fatigue-can-cost-you-your-claim/) of Kucher Law Group is drawing attention to a rising hazard on New York roads-drowsy driving-and the serious legal consequences it can bring. In a detailed article, the Brooklyn car accident lawyer explains how fatigue at the time of a crash can reduce a victim's compensation, even when another driver is primarily at fault. The absence of clear testing for fatigue allows insurance…
Long Island DWI Lawyer Jason Bassett Explains Hardship and Conditional Licenses …
For those arrested for driving while intoxicated, the immediate suspension of driving privileges can create life-changing obstacles. Long Island DWI Lawyer Jason Bassett (https://jbassettlaw.com/hardship-vs-conditional-license-in-new-york-eligibility-and-application/) outlines the differences between hardship privileges and conditional licenses in New York, offering clarity on eligibility and application steps. The Law Offices of Jason Bassett, P.C., provides valuable guidance for individuals navigating this challenging process.
Long Island DWI lawyer Jason Bassett explains that after a DWI arrest…
Gutter Masters Cleaning & Installation Protects Homes With Reliable Gutter Care …
Concord, CA - August 28, 2025 - Gutters play a crucial role in protecting homes from the costly effects of water damage, yet many property owners underestimate their importance until problems occur. In Concord and throughout Contra Costa County, Gutter Masters Cleaning & Installation [https://guttersmaster.com/gutter-repair/] has earned trust by providing professional cleaning, repair, and installation services that keep drainage systems working efficiently year-round.
Seasonal rain, falling leaves, and aging structures often…
Gutter Masters Cleaning & Installation Provides Reliable Gutter Services for Hom …
San Ramon, CA - August 28, 2025 - In the San Ramon Valley, homeowners understand how quickly neglected gutters can lead to expensive problems. Overflowing or broken systems often cause water damage, soil erosion, and even structural issues if left untreated. To help families protect their homes, Gutter Masters Cleaning & Installation offers professional cleaning, repair, and installation services tailored to local needs.
With seasonal weather patterns and tree-lined neighborhoods common…
More Releases for Palatin
Moderate Dry Eye Market Growth to Accelerate in Forecast Period (2023-2032), Del …
The Key Moderate Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Moderate Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Moderate Dry Eye pipeline products will significantly revolutionize the Moderate Dry Eye market dynamics.
DelveInsight's "Moderate Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Mild Dry Eye Market Growth Projections 2023-2032: DelveInsight Analysis | Palati …
The Key Mild Dry Eye Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Mild Dry Eye market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Mild Dry Eye pipeline products will significantly revolutionize the Mild Dry Eye market dynamics.
DelveInsight's "Mild Dry Eye Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding…
Dry Eye Disease Market Growth Projections 2024-2034: DelveInsight Analysis | Pal …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding…
Dry Eye Disease Market to Expand Significantly by 2034, States DelveInsight Repo …
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye…
Palatin Technologies' Obesity Drug Receives FDA Orphan Designation; Phase 2 Resu …
Palatin Technologies (NYSE: PTN)* and their latest developments: Palatin's Oral MC4R Agonist Gets FDA Orphan Drug Status; Phase 2 Results in Drug Targeting $44 Billion Obesity Market Expected Any Day According to the Company, alongside results from ulcerative colitis trial; Only Oral Option in Market Currently Dominated by Injections Uniquely Positioning Palatin
In an exciting development for the biopharma market, Palatin Technologies (NYSE: PTN)* announced that it has secured FDA orphan…
Dry Eye Disease Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others.
The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics.
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding…
